A recall of seafood burgers by the Connecticut based company Caraluzzi's Markets has been issued a Class I risk ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Johnson & Johnson ’s anti-FcRn antibody nipocalimab has been approved by the FDA to treat generalized myasthenia gravis. The drug will be marketed under the brand name Imaavy.

Experts exploring what other conditions semaglutide, the active ingredient in Wegovy and Ozempic, might help apart from ...

In 2025, AquaSculpt went through one of the largest consumer trials in supplement history. Over 27,000 people participated in ...